Irreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic Cancer
Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2027-04-01
Target enrollment:
Participant gender:
Summary
This study aims to determine the safety and tolerability of combining sequential therapy of Irreversible Electroporation (IRE) and Immunotherapy (IO) for patients with locally advanced unresectable pancreas cancer following first-line treatment with chemotherapy and ablative stereotactic magnetic resonance image-guided adaptive radiation therapy (A-SMART).
Phase:
PHASE1
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute